Article Versions Notes

Kim JY, Lee JH, Jung EJ, Son YS, Park HJ, Kim JM, Park T, Jeong S-H, Lee J, Kim TH, et al. Therapeutic Targeting of the Galectin-1/miR-22-3p Axis Regulates Cell Cycle and EMT Depending on the Molecular Subtype of Breast Cancer. Cells. 2025; 14(4):310. https://doi.org/10.3390/cells14040310

Kim, Ju Yeon, Jun Ho Lee, Eun Jung Jung, Young Sim Son, Hee Jin Park, Jae Myung Kim, Taejin Park, Sang-Ho Jeong, Jinkwon Lee, Tae Han Kim, and et al. 2025. "Therapeutic Targeting of the Galectin-1/miR-22-3p Axis Regulates Cell Cycle and EMT Depending on the Molecular Subtype of Breast Cancer" Cells 14, no. 4: 310. https://doi.org/10.3390/cells14040310

Kim, J. Y., Lee, J. H., Jung, E. J., Son, Y. S., Park, H. J., Kim, J. M., Park, T., Jeong, S.-H., Lee, J., Kim, T. H., Lee, S. M., & Heo, J. D. (2025). Therapeutic Targeting of the Galectin-1/miR-22-3p Axis Regulates Cell Cycle and EMT Depending on the Molecular Subtype of Breast Cancer. Cells, 14(4), 310. https://doi.org/10.3390/cells14040310